Over the last 7 days, the Biotech industry has dropped 3.0%, driven by Moderna declining 29%. This takes the industry's 12 month performance to a gain of 15%. Looking forward, earnings are forecast to grow by 28% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 05 Aug 2024 | US$1.2t | US$165.8b | -US$32,343,076,510.84 | 25.9x | -37x | 7.2x |
Wed, 03 Jul 2024 | US$1.1t | US$164.4b | -US$27,942,623,021.72 | 28.6x | -41.1x | 7x |
Fri, 31 May 2024 | US$1.1t | US$164.6b | -US$26,676,846,840.12 | 27.1x | -41.7x | 6.8x |
Sun, 28 Apr 2024 | US$1.1t | US$164.6b | -US$27,372,800,636.09 | 22.6x | -39.1x | 6.5x |
Tue, 26 Mar 2024 | US$1.2t | US$164.3b | -US$23,900,589,317.23 | 21.6x | -48.6x | 7.1x |
Thu, 22 Feb 2024 | US$1.2t | US$168.4b | -US$20,682,314,391.88 | 13.8x | -55.7x | 6.8x |
Sat, 20 Jan 2024 | US$1.4t | US$204.8b | -US$22,506,538,466.00 | 18.5x | -63.3x | 7x |
Mon, 18 Dec 2023 | US$1.4t | US$204.7b | -US$22,123,285,336.00 | 19.2x | -61x | 6.6x |
Wed, 15 Nov 2023 | US$1.2t | US$204.7b | -US$22,084,019,583.00 | 18.8x | -54.5x | 5.9x |
Fri, 13 Oct 2023 | US$1.3t | US$207.3b | -US$13,087,317,004.00 | 16.7x | -97.1x | 6.1x |
Sun, 10 Sep 2023 | US$1.3t | US$207.5b | -US$12,633,744,533.00 | 17.4x | -101x | 6.1x |
Tue, 08 Aug 2023 | US$1.3t | US$206.8b | -US$12,334,291,943.00 | 15.3x | -101.9x | 6.1x |
Thu, 06 Jul 2023 | US$1.1t | US$186.2b | -US$16,071,351,382.00 | 13.4x | -70.3x | 6.1x |
Sat, 03 Jun 2023 | US$1.1t | US$185.9b | -US$16,006,497,567.00 | 11.4x | -71.1x | 6.1x |
Mon, 01 May 2023 | US$1.2t | US$197.1b | -US$6,664,428,484.00 | 13.7x | -173.7x | 5.9x |
Wed, 29 Mar 2023 | US$1.1t | US$198.3b | -US$4,264,607,086.00 | 13.9x | -265.9x | 5.7x |
Fri, 24 Feb 2023 | US$1.1t | US$200.7b | -US$3,634,575,903.00 | 15.6x | -312.9x | 5.7x |
Sun, 22 Jan 2023 | US$1.2t | US$203.8b | US$1.8b | 14.4x | 655.3x | 5.7x |
Tue, 20 Dec 2022 | US$1.1t | US$203.3b | US$1.6b | 14.3x | 701.1x | 5.6x |
Thu, 17 Nov 2022 | US$1.1t | US$202.3b | US$1.3b | 14.6x | 874.8x | 5.5x |
Sat, 15 Oct 2022 | US$1.0t | US$206.0b | US$5.4b | 15.6x | 194.6x | 5.1x |
Mon, 12 Sep 2022 | US$1.1t | US$206.7b | US$5.8b | 15.6x | 188.1x | 5.3x |
Wed, 10 Aug 2022 | US$1.1t | US$208.2b | US$5.6b | 16.2x | 196.7x | 5.3x |
Fri, 08 Jul 2022 | US$1.1t | US$211.5b | US$10.8b | 17.4x | 101.4x | 5.2x |
Sun, 05 Jun 2022 | US$1.0t | US$212.8b | US$11.3b | 16.4x | 88.7x | 4.7x |
Tue, 03 May 2022 | US$1.0t | US$201.0b | US$7.6b | 17.2x | 135.4x | 5.1x |
Thu, 31 Mar 2022 | US$1.3t | US$221.6b | US$11.4b | 19.2x | 115.7x | 6x |
Sat, 26 Feb 2022 | US$1.2t | US$215.7b | US$6.1b | 20.7x | 198.7x | 5.6x |
Mon, 24 Jan 2022 | US$1.2t | US$212.0b | US$2.5b | 23.1x | 493.4x | 5.8x |
Wed, 22 Dec 2021 | US$1.4t | US$211.9b | US$2.8b | 26.6x | 520.4x | 6.8x |
Fri, 19 Nov 2021 | US$1.4t | US$212.2b | US$3.3b | 27.3x | 442.8x | 6.8x |
Sun, 17 Oct 2021 | US$1.5t | US$196.3b | -US$2,602,891,005.00 | 23.6x | -565.1x | 7.5x |
Tue, 14 Sep 2021 | US$1.6t | US$196.4b | -US$2,267,737,004.56 | 21.4x | -684.7x | 7.9x |
Thu, 12 Aug 2021 | US$1.6t | US$197.0b | -US$1,662,914,785.58 | 22.5x | -938x | 7.9x |
-938x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | -2.90% | |
Healthcare | -0.23% | |
Biotech | -3.01% | |
Biotech | -3.01% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABBV AbbVie | US$189.29 | 4.0% +US$13.0b | 25.9% | PE63.1x | |
ALNY Alnylam Pharmaceuticals | US$272.05 | 15.1% +US$5.0b | 47.6% | PS14.9x | |
EXAS Exact Sciences | US$57.35 | 25.9% +US$2.2b | -32.6% | PS4.1x | |
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x |